AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02286453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benjakul recipe
Description: Benjakul recipe capsule at dose of 100 mg three times a day after meal daily for 28 days
Study NCT02286453 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: diclofenac
Description: diclofenac capsule at dose of 25 mg three times a day after meal daily for 28 days
Study NCT02693951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefotiam
Description: Prophylactic use of antibiotics group: Half an hour before endoscopic treatment, cefotiam 2.0g intravenous
Study NCT01658111 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot Group
Description: The MIT-MANUS/InMotion2 (Interactive Motion Technologies, Inc., Watertown, MA, USA) system has two translational degrees of freedom (dof): shoulder abduction-adduction (ab-ad), elbow flexion-extension (flexext).~The robotic system supports the execution of reaching movements in the horizontal plane through an assist as needed control strategy. The robot can guide the movement of the upper limb of the patients and record end-effector physical quantities such as the position, velocity, and applied forces. The device is designed to have a low intrinsic end-point impedance (i.e., be back-drivable to easily carry the weight of the patient's arm, to execute movements without constraint and offer minimal resistance. A 3-dof force transducer is placed at the robots end-effector, as well.
Study NCT01658111 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional physiotherapy
Description: Active or passive exercises.
Study NCT00672451 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: rhubarb extract
Description: titrate rhubarb extract titrated up to 6grams daily by mouth
Study NCT00672451 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo titrated up to 6 pills daily as patient tolerates
Study NCT00661843 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated Yoga style practice
Description: Intervention constitutes of 2 supervised yoga style classes per week incorporating gentle postures,relaxation and meditation sequences. In addition daily home based sessions of yogic relaxation, and meditation a an audio CD
Study NCT02292472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Description: Inject intramuscularly once in visit 2
Study NCT02292472 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Inject intramuscularly once in visit 2
Study NCT02812056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alisertib
Description: Dose Escalation Phase:~Starting dose of Alisertib: 30 mg by mouth 2 times a day on Days 1 - 7 each 21 day cycle.~Dose Expansion Phase: Maximum tolerated dose from Dose Escalation Phase.
Study NCT02812056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-228
Description: Dose Escalation Phase:~Starting dose of TAK-228: 1 mg by mouth daily Days 3 - 18, with the exception of 2 mg daily Days 3 - 7 and 10 - 14 schedule in a 21 day cycle.~Dose Expansion Phase: Maximum tolerated dose from Dose Escalation Phase.
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerized brain fitness training
Description: Will use the commercially available Posit Science product BrainHQ™ (www.brainhq.com) on tablets (e.g. iPads). Participants will complete 45-60 minutes of training daily in the program.
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Will use adapted Hatha Yoga where participants sit on armless chairs placed on sticky mats for some asana (poses) and use the chair for support throughout. This adapted Hatha Yoga style is appropriate for older adults including those who have limited mobility, use walkers or are in wheelchairs. The appropriately sequenced yoga practice meets the American College of Sports Medicine recommendation for older adults for muscle strengthening and flexibility. Instructions are modeled for the participants
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wellness Education
Description: The education component will involve daily 60-minute group sessions with topics such as Introduction to the Program, Living with MCI, Changes in Roles, Communication and Relationships, Sleep Hygiene, Steps to Healthy Brain Aging, Preventing Dementia, MCI and Depression, Nutrition, Safety and Assistive Technologies, and Participating in Research, Community Resources, Meaning and Purpose, and Joy.
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support Group (patient and partner)
Description: Journal© as a basis for reminiscence-focused group sessions. Partner: The care partner support group meets separately from the patient group for 45-60 minutes daily.
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Support Group (patient and partner)
Description: Journal© as a basis for reminiscence-focused group sessions. Partner: The care partner support group meets separately from the patient group for 45-60 minutes daily.
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation
Description: Will provide each couple with memory compensation training 5 days per week for 2 weeks, with initial and ending adherence sessions. All sessions will involve 45- 60 minutes of training. The curriculum is described briefly here.~Learning phases. three training stages from learning theory: 1) an acquisition phase in which use of the memory compensation system is learned, 2) an application phase in which a participant is taught to apply to his/her daily life, and 3) an adaptation phase in which a participant practices incorporating into his/her daily life so as to make its use habitual.
Study NCT03095170 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Rehabilitation
Description: Will provide each couple with memory compensation training 5 days per week for 2 weeks, with initial and ending adherence sessions. All sessions will involve 45- 60 minutes of training. The curriculum is described briefly here.~Learning phases. three training stages from learning theory: 1) an acquisition phase in which use of the memory compensation system is learned, 2) an application phase in which a participant is taught to apply to his/her daily life, and 3) an adaptation phase in which a participant practices incorporating into his/her daily life so as to make its use habitual.
Study NCT02931370 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Dietary Supplement: Intensive dietary intervention
Description: Participants receive a hypo-caloric formula diet containing 800 to 1,000 kcal/day. The formula diet consists of ready-to-use meal bars and powders to mix with water to make shakes, soups, or porridge. The weight loss programme consists of an 8-week period with full meal replacement by a standard liquid energy intake protocol. To facilitate compliance with the programme, participants will be scheduled for weekly facility-based group sessions with 6-8 participants led by a dietician. The recommendations for daily nutrient intake will be met.
Study NCT03394131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hylase
Description: hydro-dissection injection of median nerve inside carpal tunnel using hyalase and 10 cc saline
Study NCT03394131 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: hydro-dissection injection of median nerve inside carpal tunnel using 10 IU insulin and 10 cc saline
Study NCT03394131 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: saline
Description: hydro-dissection injection of median nerve inside carpal tunnel using 10 cc saline
Study NCT01004523 — intervention group
Intervention type: GENETIC
Intervention: fluorescence in situ hybridization
Study NCT01004523 — intervention group
Intervention type: GENETIC
Intervention: loss of heterozygosity analysis
Study NCT01004523 — intervention group
Intervention type: GENETIC
Intervention: polymerase chain reaction
Study NCT01004523 — intervention group
Intervention type: OTHER
Intervention: flow cytometry
Study NCT01004523 — intervention group
Intervention type: OTHER
Intervention: immunohistochemistry staining method
Study NCT01896726 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Administered orally
Study NCT01896726 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microgynon
Description: Administered orally
Study NCT04311645 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Activated charcoal
Description: Activated charcoal
Study NCT04311645 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Dry seeds
Description: Dry seeds
Study NCT02744170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 1 continuous flow oxygen supplementation
Description: This oxygen Supplementation is used in special order
Study NCT02744170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2 demand delivery liquid oxygen supplementation
Description: This oxygen Supplementation is used in special order
Study NCT02744170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3 demand delivery oxygen supplementation via concentrator
Description: This oxygen Supplementation is used in special order
Study NCT00705601 — intervention group
Intervention type: PROCEDURE
Intervention: PSG
Description: PSG (polysomnography) for adaptation night, day 2 evening, and day 3 evening--used to identify suitable Nonrestorative Sleep candidates to participate in focus groups.
Study NCT00487032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxymetazoline 0.05% w/v
Description: 2 squirts in each nostril thrice daily
Study NCT00487032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 50 micrograms per actuation
Description: 2 Squirts in each nostril twice daily
Study NCT00487032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prazosin hydrochloride
Description: Prazosin 1mg one dose only
Study NCT00487032 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to Prazosin
Description: Placebo 1 tablet one dose only
Study NCT02134509 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental App
Description: It is comprised of twenty-two modules of 10-15 minutes each, designed to teach behavioral strategies for smoking cessation using psychoeducation-based audio and videos, animations to reinforce key concepts, and in vivo exercises. In addition, 5 bonus modules become available upon completion of earlier modules; these may be accessed for additional practices to bolster other modules
Study NCT02134509 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator App
Description: It is comprised of 6 prompts per day asking individuals about their experience, behavior, and smoking habits, for 22-days.
Study NCT01342432 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: General exercise only
Description: exercises for stretch and strength of paraspinal and abdominal muscles
Study NCT01342432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance reeducation plus general exercise
Description: patients perform balance reeducation exercises in addition to general exercises for stretch and strength of back and abdominal muscles
Study NCT01656213 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Computer-based target pursuit task (created using E-Prime software) and visual-feedback handgrip force transducer (CurrentDesigns 2012).
Description: Subjects will be encouraged to perform the exercise 2-3 times per dialysis session depending upon mood, although will be permitted to skip sessions if they do not feel well or motivated. The laptop program time-stamps each session, and records a time-series of duration, force and accuracy of hand grip.
Study NCT01594645 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sperm selection by conventional / polarized light microscopy
Description: Selecting spermatozoa for ICSI using conventional and polarized light microscopy
Study NCT01594645 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sperm selection by conventional / polarized light microscopy
Description: Selecting spermatozoa for ICSI using conventional and polarized light microscopy
Study NCT04119843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mangoral
Description: 800 mg manganese chloride \[II\] tetrahydrate, 500 mg L-alanine, and 800 IU vitamin D3
Study NCT00856245 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Rituximab
Description: 375 MG/M2 (milligram per meter squared) given IV (intravenously) weekly x 4-8 doses.
Study NCT01512550 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: GF hip guide
Description: Using GF hip guide to measure and control the peroperative positioning of the hip stem
Study NCT01512550 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stryker Navigation System
Description: Using Orthomap Modular Hip Software to navigate the operation
Study NCT01512550 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ABG II modular femoral component
Description: A hip prosthesis made by Stryker. It has the same basic shape as the ABG II femoral component but has a modular neck system allowing it to better follow the patient specific hip anatomy regarding offset, varus-valgus angle and rotation in the anteroposterior plane.
Study NCT01814072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 12 Telephone Coaching Sessions
Description: Participants will receive 12 telephone coaching sessions
Study NCT01814072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 24 Telephone Coaching Sessions
Description: Participants will receive 24 telephone coaching sessions
Study NCT01814072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Report to Primary Care Physician
Description: Participants will have a report detailing their weight loss progress sent to their primary care physician
Study NCT01814072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text Messages
Description: Participants will receive regular text messages
Study NCT01814072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recommendations to use meal replacements
Description: Participants will receive recommendations from their coach to use meal replacements
Study NCT01814072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy Training
Description: Participants will have a buddy that will be trained via webinars to be a supportive buddy
Study NCT01241331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLI1100
Description: BLI110 topical cream
Study NCT01241331 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle cream
Description: Vehicle topical cream
Study NCT00760747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Description: 1.2 mg/kg/day up to 1.8 mg/kg/day, orally (PO)
Study NCT01816347 — intervention group
Intervention type: PROCEDURE
Intervention: Routine PCI
Study NCT00592189 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blood draw
Description: blood collection
Study NCT01021371 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Two step intervention including patient interview followed by an extended information routine to the patients' GP about the patients' rehabilitation needs
Description: The intervention consists of an extended information routine from hospital to GP based on individual interviews with the patients in the intervention group and a specific encouragement of the patients' GP to play a proactive role in the patients' rehabilitation course. The individual needs concerning the different types of consequences of the disease and following rehabilitation needs will be brought into focus. The control group is assigned to usual procedures.
Study NCT04115189 — intervention group
Intervention type: DRUG
Intervention: Sunitinib
Description: Patients to receive Sunitinib as first line therapy for mRCC
Study NCT02529423 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multi-nutrient supplement
Description: * Omega 3 fatty acids~* Folic acid~* Calcium~* Selenium~* Vitamin D3
Study NCT02529423 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation
Description: 21 sessions (15 individual sessions and 6 group sessions) The intervention will include detailed analysis of each individual's behavior to determine idiosyncratic triggers and functions of unhelpful (e.g., mood-related snacking) and helpful food-related behavior, thereby, to reinforce helpful behaviors and to implement effective alternatives to unhelpful behaviors, building on behavioural approaches proven effective in depression.
Study NCT02110628 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Roux-en-Y anastomosis
Description: Roux-en-Y anastomosis
Study NCT02110628 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Roux-en-Y+Pouch anastomosis
Description: Roux-en-Y+Pouch anastomosis
Study NCT04052516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Icosabutate
Description: Icosabutate oral capsule once daily
Study NCT04052516 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo oral capsule
Study NCT00864305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin 400 mg capsules
Description: A: Experimental Subjects received Purepac formulated products under fed conditions
Study NCT00864305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NEURONTIN® 400 mg capsules
Description: B: Active comparator Subjects received Parke-Davis's marketed product
Study NCT00864305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin 400 mg capsules, single dose
Description: C: Experimental Subjects received Purepac formulated products under fasting conditions
Study NCT03574688 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Water
Description: Increased daily water intake with 1.5 Liters of water per day on top of habitual water intake.
Study NCT02529423 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pills identical in look and taste but including no active ingredients
Study NCT02529423 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo pills identical in look and taste but including no active ingredients
Study NCT02365038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Driving pressure limited ventilation
Description: We will use volume controlled ventilation or pressure support in the weaning phase. We will adjust tidal volume between 3 and 8 mL/Kg of predicted body weight in order to achieve a driving pressure of 13 cmH2O. The respiratory rate will be titrated to achieve a pH between 7.30 and 7.45 (maximum respiratory rate is 50 breathings per minute). We will not limit plateau pressure in this arm.
Study NCT02365038 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional ventilation
Description: ARDSNet Strategy: conventional mechanical ventilation strategy with tidal volume between 4 and 6 mL/kg of predicted body weight and plateau pressure limited to 30 cmH2O.
Study NCT03323697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SZ-05
Description: 2.5g a day (3 capsules twice a day)
Study NCT03323697 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Escitalopram Pill
Description: 10 mg capsule plus 5 placebo capsules
Study NCT00222014 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TIPS
Description: Transjugular intrahepatic portosystemic shunt with covered PTFE
Study NCT00222014 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Paracenthese
Description: Paracenthese
Study NCT04515277 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 40 g Gum acacia (FibregumTM)
Description: Applied in 300 mL of orange juice with breakfast (single use at visit)
Study NCT04515277 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 20 g Gum acacia (FibregumTM)
Description: Applied in 300 mL of orange juice with breakfast (single use at visit)
Study NCT04515277 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: 0 g Gum acacia (FibregumTM)
Description: 300 mL of orange juice with breakfast (single use at visit)
Study NCT02875717 — intervention group
Intervention type: DRUG
Intervention: Acetylsalicylic acid
Study NCT02875717 — intervention group
Intervention type: DRUG
Intervention: low molecular weight heparin
Study NCT05253599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Isokinetic training
Description: The knees were flexed slightly at 15 degrees, and the fixation straps were tied around the popliteus, thigh, pelvis, chest and scapula to prevent the tricky movements.
Study NCT05253599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality training
Description: Training was given in the sitting position which provides challenges to the balance activities of the participant. The game which was used in the current study was a shooting game, which consists of the subject sitting on the virtual platform and visualizing the game on the display screen. The game was executed and controlled by moving the trunk back and forth and left and right according to the signs. Participants can perform all the six movements of their spine within their pain limits.~The level of difficulty of the exercises was increased by graded activity, in which the activities were gradually getting difficult and harder as participants required more muscle activity and movement.